Strong Growth Ahead: Drug-Coated Balloons Market Size To Grow At Arecord 15.6% Cagr By 2029

The Drug-Coated Balloons Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

How Big Is the Drug-Coated Balloons Market Size Expected to Be by 2034?
The Drug-Coated Balloons Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

How Big Is the Drug-Coated Balloons Market Size Expected to Be by 2034?

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10829

What Are the Emerging Segments Within the Drug-Coated Balloons Market?
The drug-coated balloons market covered in this report is segmented -

1) By Product: Drug-Coated Balloons For Peripheral Artery Disease, Drug-Coated Balloons For Coronary Artery Disease, Drug-Coated Balloons For Other Indications
2) By Drug Type: Paclitaxel, Sirolimus
3) By End User: Hospitals, Cardiac Catheterization Labs, Ambulatory Surgical Centers

Subsegments:
1) By Drug-Coated Balloons For Peripheral Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons
2) By Drug-Coated Balloons For Coronary Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons, Everolimus-Coated Balloons
3) By Drug-Coated Balloons For Other Indications: Drug-Coated Balloons For Femoropopliteal Lesions, Drug-Coated Balloons For Renal Artery Lesions, Drug-Coated Balloons For Other Vascular Applications

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10829&type=smp

What Long-Term Drivers Are Shaping Drug-Coated Balloons Market Trends?
The increasing occurrence of coronary artery disease could spur the expansion of the drug-coated balloons market. Coronary artery disease (CAD) is a health issue characterized by the constriction or blockage of the coronary arteries that supply blood to the heart muscle, leading to heart attacks. The drug-coated balloon is a medical tool utilized in the management of coronary artery disease. During the procedure, the drug is released into the artery to prevent restenosis - the artery's re-narrowing after angioplasty. For instance, a study published in the Journal of the American College of Cardiology in August 2022 indicated that all four cardiovascular risk factors are expected to rise among the general U.S. population from 2025 to 2060. Diabetes showed the largest expected increase of 39.3%, followed by dyslipidemia with an increase of 27.6%, hypertension with a rise of 25.1%, and obesity with an increase of 18.3%. The researchers discovered significant anticipated increases in heart failure (33.4%) and ischemic heart disease (30.7%), followed by heart attack (16.9%) and stroke (33.8%). Therefore, the expected increase in the incidence of coronary artery disease is likely to stimulate the drug-coated balloon market.

Who Are the Top Competitors in Key Drug-Coated Balloons Market Segments?
Major companies operating in the drug-coated balloons market include Acotec Scientific AG, B. Braun Melsungen AG, Biosensors International Group Ltd, Medtronic Inc., Boston Scientific Corporation, Opto Circuits, Concept Medical, Cardionovum GmbH, Endocor GmbH, Hexacath Sverige, iVascular SLU, Minvasys SAS, MedAlliance, QT Vascular Ltd, Terumo Corporation, Biotronik, Cook Medical, Cordis Corporation, Abbott Laboratories, Surmodics Inc., Hexacath SAS, MicroPort, SurModics Inc., Orchestra BioMed

What Drug-Coated Balloons Market Trends Are Gaining Traction Across Different Segments?
The increasing trend of product innovations in the drug-coated balloon market is becoming widely popular. Major market stakeholders are adopting strategies involving technological advancements and introducing unique solutions to enhance their market presence. For instance, Becton, Dickinson, and Company (BD), a firm focused on medical technology based in the U.S, kicked off the PREVISION first-in-human trial for a peripheral sirolimus drug-coated balloon (DCB) in August 2022. The aim of this trial is to evaluate the safety and efficacy of the sirolimus DCB when used to treat patients suffering from peripheral artery disease that significantly hampers mobility and life quality.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/drug-coated-balloons-global-market-report

Which Regions Are Becoming Hubs for Drug-Coated Balloons Market Innovation?
North America was the largest region in the global drug-coated balloons market in 2024, and is expected to be the fastest-growing region in the forecast period. The regions covered in the drug-coated balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Drug-Coated Balloons Market?
2. What is the CAGR expected in the Drug-Coated Balloons Market?
3. What Are the Key Innovations Transforming the Drug-Coated Balloons Industry?
4. Which Region Is Leading the Drug-Coated Balloons Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.